The new heart allocation system that went into effect in last 2018 has impacted the way we surgically treat heart failure. This session will give insights into the current state of heart transplantation including non-traditional donor utilization as well as the impact of the new allocation on mechanical circulatory support devices.

*Unless otherwise noted, speakers have nothing to disclose.

Moderators

Ahmet Kilic (Commercial Relationships: Medtronic, Abiomed: Consultant/Advisory Board)

John Stulak

Presentations:

1. Investigating the Impact of the UNOS Heart Allocation Policy Change on the Patients Receiving Temporary Mechanical Circulatory Support as a Bridge-to-Transplant - Lulia Barbur

2. The Impact of the New Allocation System on Both Temporary and Durable Mechanical Circulatory Support Devices - Leora Yarboro

3. Impact of the 2018 Adult Heart Allocation Policy Change on Disparities between Low- and High-Volume Transplant Centers - Samuel Kim

4. 30-Year Trends in 6-Month Mortality and Graft Failure After Heart Transplant: Modeled Analysis of the Scientific Registry of Transplant Recipients 1989-2017 Adjusted for a Changing Population - Marlena Sabatino

5. Nontraditional Donors: DCD - Lessons Learned From Initial Experience - Carmelo Milano

6. Worldwide Experience of a Novel Minimally Invasive Temporary Left Ventricular Assist Device - Edward Soltesz

Commercial Relationships: Abbott: Speaker/Honoraria; Abiomed: Speaker/Honoraria; Atricure: Speaker/Honoraria

7. Panel Discussion